Cordyceps Sunshine Biotech Holdings Co., Ltd.

Cordyceps Sunshine Biotech Holdings Co., Ltd. (ticker: RAJAF) is an OTC-listed medicinal chemicals & botanical products company. DredgeCap's structured extraction of RAJAF's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. RAJAF reported $1.25M in revenue and -$226K for the period ending 2024-12-31, with operating cash flow of $312K. Cash and equivalents stood at $37K (up 61.4% year-over-year). Total assets of $4.62M are exceeded by total liabilities of $5.00M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

RAJAF Cash Runway

Months-of-runway analysis for RAJAF, derived directly from SEC XBRL: latest cash and operating cash flow, monthly burn rate, runway under current conditions. Historical trend + verbatim citation panel ships in Phase 2.

Coming in Phase 2

The dedicated per-ticker cash-runway page will surface a 6-8 quarter trend with the underlying us-gaap:CashAndCashEquivalentsAtCarryingValue + us-gaap:NetCashProvidedByUsedInOperatingActivities citations alongside each data point. In the meantime, see the ranked cross-company view:

All companies ranked by months-of-runway →

Related on RAJAF

Share-count dilution →

Dilution is the natural counterpart to runway burn.

Going-concern history →

Auditor + management language across filings.